Patents by Inventor Davis L. Temple

Davis L. Temple has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of kappa-conotoxin PVIIA
    Publication number: 20040092447
    Abstract: The invention relates to uses of kappa-conotoxin PVIIA (&kgr;-PVIIA), analogs and derivatives for activating ATP-sensitive K+ channels. The activation of ATP-sensitive K+ channels is useful for opening KATP channels which can be used to treat a wide range of disease and injury states, including cerebral and cardiac ischemia and asthma.
    Type: Application
    Filed: July 28, 2003
    Publication date: May 13, 2004
    Applicant: Cognetix, Inc.
    Inventors: Ann H. Cornell-Bell, Karen E. Pemberton, Davis L. Temple, Richard T. Layer, R. Tyler McCabe, Robert M. Jones
  • Kappa-PVIIA-related conotoxins as organ protectants
    Publication number: 20030224343
    Abstract: The invention relates to &kgr;-PVIIA-related conotoxins and their use as organ protecting agents, i.e., organ protectants. These conotoxins can be used for arresting, protecting or preserving an organ, such as a circulatory organ, a respiratory organ, a urinary organ, a digestive organ, a reproductive organ, an endocrine organ or a neurological organ. These conotoxins can also be used for arresting, protecting or preserving somatic cells.
    Type: Application
    Filed: January 28, 2003
    Publication date: December 4, 2003
    Applicants: University of Utah Research Foundation, Cognetix, Inc.
    Inventors: Karen Pemberton-Goodman, Robert M. Jones, Davis L. Temple, J. Michael McIntosh, Baldomero M. Olivera
  • Method for regulation of transmembrane chloride conductance
    Patent number: 5621007
    Abstract: Methods for the therapy of cystic fibrosis and multi-drug resistance in cancer chemotherapy by administering to a patient in need thereof 5-trifluoroethyl-1-(5-chloro-2-hydroxyphenyl)-1,3-dehydro-2H-benzimidazol- 2-one (NSOO4) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: April 15, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Valentin K. Gribkoff, Steven I. Dworetzky, Davis L. Temple
  • Method for alleviation of vascular headache
    Patent number: 4847252
    Abstract: Tiospirone and its pharmaceutically acceptable salts are useful in alleviation of vascular or vascular-related headaches such as migraine, cluster, muscle-contraction, and combined headaches.
    Type: Grant
    Filed: October 25, 1988
    Date of Patent: July 11, 1989
    Assignee: Bristol-Myers Company
    Inventors: Davis L. Temple, Michael F. Rafferty, Michael S. Eison, Stacy N. Suberg